125 filings
Page 4 of 7
6-K
4rvmjg
2 Jan 20
Current report (foreign)
5:09pm
6-K
o8ps78gp2xern3zph
2 Jan 20
Current report (foreign)
11:43am
6-K
gz3upct8 yn
20 Dec 19
Current report (foreign)
11:25am
6-K
b527l2no
19 Dec 19
Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics
11:42am
6-K
s70 ywhsutb9
17 Dec 19
Current report (foreign)
1:26pm
6-K
pz99fr4j16qsh0uhi9
13 Dec 19
Current report (foreign)
7:54am
6-K
wmkdz 8eh815t75m
6 Dec 19
Current report (foreign)
12:00am
6-K
n3rei2
6 Dec 19
Current report (foreign)
12:00am
6-K
b5buo
5 Dec 19
Genmab Achieves USD 100 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
9:28am
6-K
dkm0n5 s2
19 Nov 19
Current report (foreign)
1:07pm
6-K
wwqhjx64tdul7j2dcn
13 Nov 19
Current report (foreign)
1:37pm
6-K
8if7vq2dda9v
12 Nov 19
Current report (foreign)
4:42pm
6-K
domwpj3lhbbhfkcpv
12 Nov 19
Capital Increase in Genmab as a Result of Employee Warrant Exercise
3:08pm
6-K
rt8gbf9n
6 Nov 19
Interim Report for the First Nine Months Ended September 30, 2019
3:37pm
6-K
byhehb
30 Oct 19
Current report (foreign)
5:11pm
6-K
mkb347f
22 Oct 19
Current report (foreign)
9:45am
6-K
er7o2u7qttwx8bjtikru
18 Oct 19
CHMP Issues Positive Opinion Recommending DARZALEX® (Daratumumab) in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
9:25am
6-K
zsj8h7ytv1r5bl
17 Oct 19
Current report (foreign)
1:19pm
6-K
0ctbjsgw9vtkyyp
15 Oct 19
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2019
8:21am
6-K
u0v yz99f8
2 Oct 19
Capital Increase in Genmab as a Result of Employee Warrant Exercise
3:50pm